RRD Simplifies the Production and Distribution of Medical Device Recall Notices

Speed, patient safety, and compliance are key drivers in this solution designed to support medical device companies and their need for immediate response

CHICAGO–(BUSINESS WIRE)–R.R. Donnelley & Sons Company (RRD), a leading global provider of marketing, packaging, print, and supply chain solutions, today announced a new solution designed to streamline the product recall communication process for medical device companies. Seamlessly integrating RRD’s highly refined capabilities in content creation, production management, and multichannel distribution, this solution aims to ensure end-to-end support throughout this complex notification process.

According to Sedgwick, a leading global provider of technology-enabled risk, benefits and integrated business solutions, FDA Class 1 recalls hit a 15-year high in 2022. With the increasing focus on patient safety and regulatory compliance, the need for immediate and effective communication during a recall is essential.

“The process to get a recall notice in the hands of the right person at the right time is complicated and urgent,” said Ken Gammon, Senior Vice President, RRD Healthcare Solutions. “Our solution removes a significant amount of the burden that medical device companies face in developing a tailored message, complying with regulations, and error-free delivery.”

HIPAA and SOC II compliant, this solution for medical device recall notices leverages a multi-location production network for speed and scale. Additional features of this solution include:

Recall-specific content platform

Proprietary automated fulfillment process

Response capture platform (i.e., reply mail, FAX receipt, web capture, and call center)

Multichannel distribution (i.e., print, email, FAX)

White glove production management service

According to John Pecaric, Chief Operating Officer at RRD, “RRD’s ability to streamline the communication process through automation and digital production of the recall notices — including integrating shipping labels with custom envelopes — will help our clients react with greater efficiency without having to compromise quality, compliance, or the safety of patients or members.”

For more information about RRD’s recall notices solution for the medical device industry, visit www.rrd.com/recall-notices.

About RRD

RRD is a leading global provider of marketing, packaging, print, and supply chain solutions that elevate engagement across the complete customer journey. The company offers the industry’s most trusted portfolio of creative execution and world-wide business process consulting, with services designed to lower environmental impact. With 25,000 clients, including 92% of the Fortune 100, and 32,000 employees across 29 countries, RRD brings the expertise, execution, and scale designed to transform customer touchpoints into meaningful moments of impact.

Contacts

Katie O’Rourke

Director, RRD Corporate Communications

[email protected]
312.326.7168

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.